Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Benefit of Niraparib to TKI/mTORi-Resistance Metastatic ccRCC With BAP1-Frame Shift Mutation: Case Report and Literature Review. | Front Oncol | 2022 | 35875073 | PubTator, text mining | PubMed |
| Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis. | Front Cell Dev Biol | 2022 | 35874839 | PubTator, text mining | PubMed |
| The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer. | Clin Genitourin Cancer | 2022 | 35871039 | PubTator, text mining | PubMed |
| Chromatin Ubiquitination Guides DNA Double Strand Break Signaling and Repair. | Front Cell Dev Biol | 2022 | 35865631 | PubTator, text mining | PubMed |
| RAD21 Confers Poor Prognosis and Affects Ovarian Cancer Sensitivity to Poly(ADP-Ribose)Polymerase Inhibitors Through DNA Damage Repair. | Front Oncol | 2022 | 35860572 | PubTator, text mining | PubMed |
| LncRNA CTBP1-DT-encoded microprotein DDUP sustains DNA damage response signalling to trigger dual DNA repair mechanisms. | Nucleic Acids Res | 2022 | 35849344 | PubTator, text mining | PubMed |
| Functional Restoration of BRCA1 Nonsense Mutations by Aminoglycoside-Induced Readthrough. | Front Pharmacol | 2022 | 35837282 | PubTator, text mining | PubMed |
| CASC1 Expression in Bladder Cancer Is Regulated by Exosomal miRNA-150: A Comprehensive Pan-Cancer and Bioinformatics Study. | Comput Math Methods Med | 2022 | 35836922 | PubTator, text mining | PubMed |
| Genetic Risk of Second Primary Cancer in Breast Cancer Survivors: The Multiethnic Cohort Study. | Cancer Res | 2022 | 35834270 | PubTator, text mining | PubMed |
| DNA repair as a shared hallmark in cancer and ageing. | Mol Oncol | 2022 | 35834102 | PubTator, text mining | PubMed |
| Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer. | Clin Cancer Res | 2022 | 35833951 | PubTator, text mining | PubMed |
| Gilteritinib Enhances Anti-Tumor Efficacy of CDK4/6 Inhibitor, Abemaciclib in Lung Cancer Cells. | Front Pharmacol | 2022 | 35814226 | PubTator, text mining | PubMed |
| Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial. | Lancet Oncol | 2022 | 35810751 | PubTator, text mining | PubMed |
| Genetic variation associated with condensate dysregulation in disease. | Dev Cell | 2022 | 35809564 | PubTator, text mining | PubMed |
| Functions of Breast Cancer Predisposition Genes: Implications for Clinical Management. | Int J Mol Sci | 2022 | 35806485 | PubTator, text mining | PubMed |
| Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted. | Int J Mol Sci | 2022 | 35806243 | PubTator, text mining | PubMed |
| Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer. | Cancers (Basel) | 2022 | 35805063 | PubTator, text mining | PubMed |
| An Overview on Radiation Sensitivity in Hereditary Breast and Ovarian Cancer Syndrome. | Cancers (Basel) | 2022 | 35805026 | PubTator, text mining | PubMed |
| Surgical Management of Inherited Breast Cancer: Role of Breast-Conserving Surgery. | Cancers (Basel) | 2022 | 35805017 | PubTator, text mining | PubMed |
| Analysis of the Clinical Advancements for BRCA-Related Malignancies Highlights the Lack of Treatment Evidence for BRCA-Positive Male Breast Cancer. | Cancers (Basel) | 2022 | 35804947 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=51